Takeda Pharmaceutical Company Limited
TKPHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11,729,000 | $124,279,000 | -$103,098,000 | $23,835,000 |
| Dep. & Amort. | $184,982,000 | $181,636,000 | $189,769,000 | $186,955,000 |
| Deferred Tax | $39,903,000 | $26,351,000 | -$4,201,000 | $2,572,000 |
| Stock-Based Comp. | $18,731,000 | $16,531,000 | $17,627,000 | $18,300,000 |
| Change in WC | $21,938,000 | -$33,701,000 | $2,873,000 | $88,759,000 |
| Other Non-Cash | $124,403,000 | -$99,673,000 | $119,189,000 | $63,335,000 |
| Operating Cash Flow | $378,228,000 | $215,423,000 | $222,159,000 | $383,756,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$40,095,000 | -$47,913,000 | -$48,793,000 | -$45,088,000 |
| Net Acquisitions | $417,000 | $29,291,000 | $67,653,000 | $1,260,000 |
| Inv. Purchases | -$1,550,000 | -$215,000 | -$2,086,000 | -$67,573,000 |
| Inv. Sales/Matur. | $2,882,000 | $1,128,000 | $2,764,000 | $3,563,000 |
| Other Inv. Act. | -$9,787,000 | -$15,484,000 | -$39,219,000 | -$7,717,000 |
| Investing Cash Flow | -$48,133,000 | -$33,193,000 | -$19,681,000 | -$115,555,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $36,555,000 | $22,000 | -$203,502,000 | -$470,878,000 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$51,603,000 | -$49,978,000 | $0 |
| Dividends Paid | -$8,787,000 | -$145,295,000 | -$9,738,000 | -$145,451,000 |
| Other Fin. Act. | -$39,749,000 | -$18,024,000 | -$38,574,000 | -$39,640,000 |
| Financing Cash Flow | -$11,981,000 | -$214,900,000 | -$301,792,000 | -$655,969,000 |
| Forex Effect | $13,364,000 | -$2,435,000 | -$9,700,000 | $22,879,000 |
| Net Chg. in Cash | $331,478,000 | -$35,105,000 | -$109,013,000 | -$364,889,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $350,008,000 | $385,113,000 | $494,126,000 | $859,015,000 |
| End Cash | $681,486,000 | $350,008,000 | $385,113,000 | $494,126,000 |
| Free Cash Flow | $325,403,000 | $140,355,000 | $129,435,000 | $327,105,000 |